Tech Company Financing Transactions
NeuroVasc Technologies Funding Round
On 5/22/2018, NeuroVasc Technologies raised $6.3 million in Series B financing from Shangbay Capital and private investors.
Transaction Overview
Company Name
Announced On
5/22/2018
Transaction Type
Venture Equity
Amount
$6,300,000
Round
Series B
Investors
Shangbay Capital (Lead Investor) (William Dai)
Proceeds Purpose
We have been seeing good early clinical results, and we plan to expand on this clinical work with the current financing.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
23141 Verdugo Dr. 105
Laguna Hills, CA 92653
USA
Laguna Hills, CA 92653
USA
Phone
Email Address
Overview
NeuroVasc, Inc. is a privately-held medical device company founded in 2015 focused on developing innovative, state-of-the-art devices for the treatment of neurovascular conditions, such as strokes.
Management Team
Browse more venture capital transactions:
Prev: 5/22/2018: Outreach venture capital transaction
Next: 5/22/2018: Zapata Computing venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC transactions reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs